These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 16693721)
1. STUDIES IN SCARLET FEVER: I. The Amount of Scarlatinal Toxin in the Blood of Patients with Scarlet Fever. Trask JD J Clin Invest; 1926 Dec; 3(2):391-6. PubMed ID: 16693721 [No Abstract] [Full Text] [Related]
2. A QUANTITATIVE STUDY OF THE SCARLET FEVER TOXIN-ANTITOXIN FLOCCULATION REACTION. Hottle GA; Pappenheimer AM J Exp Med; 1941 Nov; 74(6):545-56. PubMed ID: 19871154 [TBL] [Abstract][Full Text] [Related]
3. OBSERVATIONS ON THE PRESENCE OF A TOXIC SUBSTANCE IN THE BLOOD AND URINE OF PATIENTS WITH SCARLET FEVER. Trask JD; Blake FG J Exp Med; 1924 Aug; 40(3):381-95. PubMed ID: 19868926 [TBL] [Abstract][Full Text] [Related]
4. STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : V. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS FROM SCARLET FEVER AND ERYSIPELAS. Stevens FA; Dochez AR J Exp Med; 1926 Feb; 43(3):379-93. PubMed ID: 19869130 [TBL] [Abstract][Full Text] [Related]
6. Antigens in scarlatinal erythrogenic toxin demonstrable by the Oudin technic. JENNINGS RK J Immunol; 1953 Feb; 70(2):181-6. PubMed ID: 13035104 [No Abstract] [Full Text] [Related]
7. Treatment of scarlet fever and scarlatinal otitis with penicillin. JERSILD T Acta Med Scand; 1948; 131(Suppl 206):523-33. PubMed ID: 18881179 [No Abstract] [Full Text] [Related]
8. The incidence of serum allergy in 1,000 cases of scarlet fever treated with anti-scarlatinal serum. LIBRACH IM Med Off; 1947 Apr; 77(15):144. PubMed ID: 20295630 [No Abstract] [Full Text] [Related]
9. [Purified adsorbed scarlet fever toxin. III. Result of active immunization against scarlet fever with purified adsorbed scarlet fever toxin]. PAVLOV PV; MITEL'MAN SL; AKIMOVA VV Zh Mikrobiol Epidemiol Immunobiol; 1958 Sep; 29(9):11-5. PubMed ID: 13605085 [No Abstract] [Full Text] [Related]
10. STUDIES IN SCARLET FEVER: IV. Post-scarlatinal Immunity in Patients Treated with Antitoxin. Davies JA J Clin Invest; 1926 Dec; 3(2):423-33. PubMed ID: 16693724 [No Abstract] [Full Text] [Related]
11. STUDIES IN SCARLET FEVER: III. Infections with Streptococcus Scarlatinae in Persons with Scarlatinal Antitoxic Immunity. Nicholls EE J Clin Invest; 1926 Dec; 3(2):411-22. PubMed ID: 16693723 [No Abstract] [Full Text] [Related]
12. Erythrogenic toxin type A (ETA): epidemiological analysis of gene distribution and protein formation in clinical Streptococcus pyogenes strains causing scarlet fever and the streptococcal toxic shock-like syndrome (TSLS). Reichardt W; Müller-Alouf H; Köhler W Zentralbl Bakteriol; 1993 Jun; 279(2):283-93. PubMed ID: 8219499 [TBL] [Abstract][Full Text] [Related]
17. A Systematic Bacteriological Examination of the Fauces in Scarlet Fever as a Means of Preventing Post-Scarlatinal Diphtheria. Garratt GC; Washbourn JW Br Med J; 1899 Apr; 1(1998):893-5. PubMed ID: 20758425 [No Abstract] [Full Text] [Related]
18. [Osseous complications during scarlatinal rheumatism]. RUBERTI A Arcisp S Anna Ferrara; 1951; 4(2):163-70. PubMed ID: 14878628 [No Abstract] [Full Text] [Related]